Edition:
India

People: Biogen Inc (BIIB.OQ)

BIIB.OQ on NASDAQ Stock Exchange Global Select Market

267.12USD
20 Oct 2020
Change (% chg)

$-1.65 (-0.61%)
Prev Close
$268.77
Open
$270.45
Day's High
$271.39
Day's Low
$266.09
Volume
375,558
Avg. Vol
574,459
52-wk High
$374.94
52-wk Low
$221.80

Galdes, Alphonse 

Dr. Alphonse Galdes is Executive Vice President, Pharmaceutical Operations and Technology of the Company. Galdes is Executive Vice President, Pharmaceutical Operations and Technology of Biogen and has served on the Executive Committee since September 2019. Since joining Biogen in 1995, Galdes has held several senior executive positions, including most recently as Senior Vice President, Asset Development and Portfolio Management from November 2015 to September 2019 and Senior Vice President, Technical Development from October 2010 to November 2015. Galdes received his B.S. in Chemistry and Biology and his M.S. in Biochemistry from the University of Malta and received his Ph.D. in Biochemistry from Oxford University, where he was a Rhodes Scholar. Galdes served as a Research Associate at the Department of Biological Chemistry at Harvard Medical School.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --